# First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis

Study · id `cardio:ct-nct02236975` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02236975](<https://clinicaltrials.gov/study/NCT02236975>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02236975

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 168 participants.

## Technical summary

Registry record NCT02236975. Randomized; single masking; primary purpose treatment. Start 2015-04 (actual); primary completion 2016-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 168 participants (enrolled count; ClinicalTrials.gov record NCT02236975, source copy `cardio:ctgov-nct02236975-2020-07-28`, retrieved 2026-10-26)
- Started: 2015-04 (actual) (ClinicalTrials.gov record NCT02236975, source copy `cardio:ctgov-nct02236975-2020-07-28`, retrieved 2026-10-26)
- Primary completion: 2016-11 (actual) (ClinicalTrials.gov record NCT02236975, source copy `cardio:ctgov-nct02236975-2020-07-28`, retrieved 2026-10-26)
- Completion: 2019-03 (actual) (ClinicalTrials.gov record NCT02236975, source copy `cardio:ctgov-nct02236975-2020-07-28`, retrieved 2026-10-26)
- Countries: Belgium; Netherlands; Portugal; Spain (ClinicalTrials.gov record NCT02236975, source copy `cardio:ctgov-nct02236975-2020-07-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02236975-2020-07-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis
- Condition: Coronary Artery Disease
- Intervention (Device): BuMA Supreme Biodegradable drug coating coronary stent system
- Intervention (Device): Resolute Integrity durable polymer stent system
- Lead sponsor: Sino Medical Sciences Technology Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Sino Medical Sciences Technology Inc. (`cardio:org-sino-medical-sciences-technology-inc`)

## Provenance

Content hash: 7f037c9c04d2c66477c7a3a0877aedfc3ee47ac2bf082c8a7ed8946710f85bc4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
